The future of contraception: Innovations in contraceptive agents: Tomorrow's hormonal contraceptive agents and their clinical implications

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Currently available contraceptive methods have not eliminated the burden of unintended pregnancy. Future progress will require technological advancements, leading to the development of novel and highly effective birth control strategies that will be acceptable to the general population. Included are highlights of some of the ongoing research, demonstrating the development of methods with the potential to be highly effective, widely accepted, easy to use, and more cost-effective, with fewer side effects, than currently available options.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume205
Issue number4 SUPPL.
DOIs
StatePublished - Oct 2011

Fingerprint

Contraceptive Agents
Contraception
Costs and Cost Analysis
Pregnancy
Research
Population

Keywords

  • fertility projections
  • male contraception
  • sexually transmitted infections

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

@article{4817b1a46b3a4ea1b9b640f9cc820dcf,
title = "The future of contraception: Innovations in contraceptive agents: Tomorrow's hormonal contraceptive agents and their clinical implications",
abstract = "Currently available contraceptive methods have not eliminated the burden of unintended pregnancy. Future progress will require technological advancements, leading to the development of novel and highly effective birth control strategies that will be acceptable to the general population. Included are highlights of some of the ongoing research, demonstrating the development of methods with the potential to be highly effective, widely accepted, easy to use, and more cost-effective, with fewer side effects, than currently available options.",
keywords = "fertility projections, male contraception, sexually transmitted infections",
author = "Jeffrey Jensen",
year = "2011",
month = "10",
doi = "10.1016/j.ajog.2011.06.055",
language = "English (US)",
volume = "205",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - The future of contraception

T2 - Innovations in contraceptive agents: Tomorrow's hormonal contraceptive agents and their clinical implications

AU - Jensen, Jeffrey

PY - 2011/10

Y1 - 2011/10

N2 - Currently available contraceptive methods have not eliminated the burden of unintended pregnancy. Future progress will require technological advancements, leading to the development of novel and highly effective birth control strategies that will be acceptable to the general population. Included are highlights of some of the ongoing research, demonstrating the development of methods with the potential to be highly effective, widely accepted, easy to use, and more cost-effective, with fewer side effects, than currently available options.

AB - Currently available contraceptive methods have not eliminated the burden of unintended pregnancy. Future progress will require technological advancements, leading to the development of novel and highly effective birth control strategies that will be acceptable to the general population. Included are highlights of some of the ongoing research, demonstrating the development of methods with the potential to be highly effective, widely accepted, easy to use, and more cost-effective, with fewer side effects, than currently available options.

KW - fertility projections

KW - male contraception

KW - sexually transmitted infections

UR - http://www.scopus.com/inward/record.url?scp=80053345330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053345330&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2011.06.055

DO - 10.1016/j.ajog.2011.06.055

M3 - Article

C2 - 21961821

AN - SCOPUS:80053345330

VL - 205

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4 SUPPL.

ER -